` LGP (Little Green Pharma Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

LGP
vs
S&P/ASX 300

Over the past 12 months, LGP has underperformed S&P/ASX 300, delivering a return of -15% compared to the S&P/ASX 300's 9% growth.

Stocks Performance
LGP vs S&P/ASX 300

Loading

Performance Gap
LGP vs S&P/ASX 300

Loading
LGP
S&P/ASX 300
Difference

Performance By Year
LGP vs S&P/ASX 300

Loading
LGP
S&P/ASX 300
Add Stock

Competitors Performance
Little Green Pharma Ltd vs Peers

S&P/ASX 300
LGP
LLY
JNJ
NOVO B
ROG
Add Stock

Little Green Pharma Ltd
Glance View

Market Cap
33.2m AUD
Industry
Pharmaceuticals

Little Green Pharma Ltd. produces medicinal cannabis products for sale to Australian patients. The company is headquartered in Perth, Western Australia. The company went IPO on 2020-02-20. The Company’s products includes LGP Classic range and LGP Flower range. Its LGP Classic range includes tetrahydrocannabinol (THC) and cannabidiol (CBD) ratios presented in an oil formulation. Its LGP Flower range is grown and manufactured in the Southwest of Western Australia and supplied as dried medicinal cannabis whole flowers. The firm supplies medical-grade cannabis products to Australian, European and overseas markets. The company is also engaged in promoting education and outreach programs.

LGP Intrinsic Value
0.22 AUD
Undervaluation 50%
Intrinsic Value
Price
Back to Top